Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
CollabRx, Inc.

CollabRx, Inc. (NASDAQ: CLRX) is a company that offers cloud-based expert systems for selecting clinical treatments for molecular diseases such as cancer. Its technology revolves around dynamically updated molecular disease models that form the basis of the expert systems. One of the challenges evolving from the recent explosion in biological information is to distill actionable clinically relevant therapy approaches from the vast amount of data available. The knowledgebases that inform the models are updated by a large network of advisors from academic and medical institutions.

Investment goal date:
Dividends reinvested
CollabRx, Inc. CLRX report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
DOHRING EDWARD A
2.0400% (59663)
CLRX /
WADSWORTH DUANE
1.5700% (45924)
CLRX /
MIKA THOMAS
10.3800% (303839)
CLRX /
BROWN SCOTT L
2.0000% (58535)
CLRX /
Selbrede Steve
2.9200% (85481)
CLRX /
Tchakerian Vahan
0.3100% (9145)
CLRX /
Hergenrother Christine Terese
3.2700% (95610)
CLRX /
Goldberg Michael Louis
0.9100% (26667)
CLRX /
Muscari Carl
0.1800% (5340)
CLRX /
Werbaneth Paul
1.4200% (41639)
CLRX /
Verition Fund Management LLC
27.0100% (790319)
ACFN / CLRX /
Karis James
0.1000% (3000)
CLRX / MRNA /
Adams Jason
5.7600% (168392)
CLRX /
Sramowicz Steven
127.8200% (3739847)
CLRX /
Diamantis Christopher Eric
3.4200% (100000)
CLRX /
Lagan Seamus
6.8400% (200000)
CLRX /
Ajami Kamran
3.4200% (100000)
CLRX /
% ()